Low Dose Naltrexone (LDN) is a wonder drug that can be used to treat depression as it is associated with the central nervous system. Low-dose naltrexone (LDN) binds all non-opioid receptors transiently.

The recommendation for the scientific research of low-dose naltrexone (LDN) to treat multiple sclerosis (MS) was initially presented as a medical theory in 2005. Shortly after, an open-label multi-centered pilot trial including 40 patients evaluated the t...

Low-dose naltrexone (LDN) improves the tolerance of pain and interpersonal interactions in patients who have undergone drug detox procedures.